|1.||Francés, Rubén: 19 articles (06/2015 - 07/2002)|
|2.||Such, José: 18 articles (06/2015 - 07/2002)|
|3.||Zapater, Pedro: 14 articles (07/2014 - 07/2002)|
|4.||Pérez-Mateo, Miguel: 12 articles (08/2011 - 07/2002)|
|5.||Muñoz, Carlos: 8 articles (12/2008 - 07/2002)|
|6.||Pascual, Sonia: 7 articles (12/2008 - 07/2002)|
|7.||González-Navajas, José M: 6 articles (02/2014 - 09/2006)|
|8.||Obermeier, Florian: 6 articles (10/2010 - 07/2002)|
|9.||Bellot, Pablo: 5 articles (12/2010 - 01/2008)|
|10.||Falk, Werner: 5 articles (10/2010 - 07/2002)|
01/01/2015 - "Bacterial DNA was extracted from reposited cervicovaginal lavage samples collected annually over an 8-10 year period from Chicago Women's Interagency HIV Study participants: 22 HIV-negative, 22 HIV-positive with stable infection, 20 HIV-positive with progressive infection. "
01/01/2013 - "PCR enabled to detect the bacterial DNA in the liver, spleen and lungs of chickens until the 9th day after infection and in case of tibiotarsal joint during the whole time of the study."
10/22/2015 - "burnetti infection was sought in domestic, wild and captive animals based on the detection of bacterial DNA. "
10/01/2015 - "Hospital environments influence healthcare-associated infection (HAI) patterns, but the role of evidenced-based design (EBD) and residual bacterial DNA (previously thought to be clinically inert) remain incompletely understood. "
10/01/2015 - "AZD0914, a new spiropyrimidinetrione bacterial DNA gyrase inhibitor with a novel mode of inhibition, has activity against bacterial species commonly cultured from patient infection specimens, including fluoroquinolone-resistant isolates. "
10/01/2010 - "T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells."
01/01/2010 - "Bacterial DNA has been shown to be protective against experimental colitis. "
07/01/2002 - "In conclusion, CpG-motifs of bacterial DNA have proinflammatory activity by strengthening the Th1 arm of immunity in DSS-induced colitis, and might therefore play a significant role in the initiation and perpetuation of inflammation in IBD."
11/01/2011 - "Increased expression of cathelicidin in monocytes and experimental models of colitis involves activation of TLR9-ERK signaling by bacterial DNA. "
11/01/2011 - "Intracolonic administration of bacterial DNA to wild-type mice induced expression of cathelicidin in colons of control mice and mice with DSS-induced colitis. "
07/01/2014 - "Multivariate analyses revealed bacterial DNA as an independent significant factor, explaining the systemic cytokine response and the insulin resistance levels in the studied population. "
07/01/2014 - "Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbid obese patients."
07/01/2014 - "Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbidly obese patients despite significant weight loss."
07/01/2014 - "Proinflammatory cytokines, serum endotoxin levels, and insulin resistance remained increased in patients with bacterial DNA despite weight loss and were individually affected by the appearance/clearance of bacterial DNA in blood. "
01/01/2008 - "Treatment with norfloxacin and ampicillin for 2 weeks reduced the cecal bacterial DNA below the level of detection in ob/ob, diet-induced obese and insulin resistance (DIO) mice, and significantly improved fasting glycemia and oral glucose tolerance of the treated animals. "
02/01/2014 - "The observation of bacterial DNA translocation in patients with CD led us to hypothesise that this process may be facilitated in patients with NOD2/ATG16L1-variant genotypes, affecting the efficacy of anti-tumour necrosis factor (TNF) therapies. "
09/01/2011 - "Whole peripheral blood samples obtained immediately after admission were stimulated with bacterial DNA and production of tumour necrosis factor (TNF) α was then determined. "
12/01/2008 - "History and clinical examination were done with the following investigations at first admission and followed up for 24 weeks: serum and AF tumour necrosis factor-alpha (TNF-alpha), AF polymorphonuclear leukocytes, AF cultivation and detection of blood and AF bacterial DNA. "
01/01/2008 - "Tumour necrosis factor-alpha and interleukin-6 were significantly increased in patients with vs without bacterial-DNA (324.93+/-70.76 vs 134.91+/-34.58microg/mL; p<0.05; 294.96+/-87.48 vs 175.92+/-60.58microg/mL, p < 0.05, respectively). "
04/01/2002 - "Bacterial DNA, especially that enriched in CpG motifs, is a powerful immunostimulant that may, in some cases, lead to ACA or anti-DNA positivity, once tumour necrosis factor alpha is blocked. "
01/01/2015 - "Bacterial translocation (BT) or bacterial DNA (bactDNA) translocation is a critical pathogenesis mechanism of spontaneous bacterial peritonitis. "
08/01/2013 - "Although plasma bacterial DNA level seems to predict patient survival and peritonitis-free survival, the association disappears after adjusting for confounding factors. "
08/01/2013 - "Similarly, peritonitis-free survival were 60.6, 59.8, 60.3 and 50.4% for plasma bacterial DNA level quartiles I, II, III and IV, respectively, at 36 months (P = 0.020), and the difference was not significant after adjusting for confounding factors. "
01/01/2011 - "Bacterial DNA was not detected in almost half the culture-negative spontaneous bacterial peritonitis episodes. "
01/01/2011 - "Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis."
|2.||DNA (Deoxyribonucleic Acid)
|5.||Anti-Bacterial Agents (Antibiotics)
|6.||Antineutrophil Cytoplasmic Antibodies (ANCA)
|1.||Prostheses and Implants (Prosthesis)
|4.||Renal Replacement Therapy (Therapies, Renal Replacement)